GL1X · GenesisL1 explorer

MolNFT v1 · #169896 · protein

Receptor for advanced glycation end products VC1 domain in complex with fragments 1 & 13

6XQ9: “Receptor for advanced glycation end products VC1 domain in complex with fragments 1 & 13”. X-ray diffraction, 2 ligands (V6S, V6M). MolNFT v1 #169896 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6XQ9
Type
protein
Length
424 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q15109
Ligands
V6S, V6M

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B—protein212—Q15109

Ligands and binding sites

  • V6S · 4-(3-hydroxyphenoxy)benzoic acid · ligand · 4 copies · chains A, B
  • V6M · 7-methyl-3-phenyl-1H-indole-2-carboxylic acid · ligand · 2 copies · chains A, B
  • ACT · Acetate ion · additive · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6XQ9 · Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 13 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q15109 · AlphaFold monomer V2.0 prediction for advanced glycosylation end product-specific… · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.